Recombinant PSMA (Rosopatamab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA, WB
Hôte: Humanized
Chimeric
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits PSMA (Rosopatamab Biosimilar)
- PSMA (Rosopatamab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Humanized
- Expression System
- Mammalian cells
-
Clonalité
- Chimeric
-
Conjugué
- Cet anticorp PSMA (Rosopatamab Biosimilar) est non-conjugé
- Application
- ELISA, Western Blotting (WB)
- Fonction
- Rosopatamab Biosimilar - Anti-FOLH1 mAb - Research Grade
- Attributs du produit
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Pureté
- > 85%
- Classe de qualité
- Research Grade
- Isotype
- IgG1 kappa
-
anti-PSMA (Rosopatamab Biosimilar) antibody
Research Grade Reactivité: Humain ELISA, FACS Hôte: Souris Chimeric unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Stock
- -80 °C
- Stockage commentaire
- store at -80°C
-
- Antigène
- PSMA (Rosopatamab Biosimilar)
- Abstract
- PSMA (Rosopatamab Biosimilar) Produits
- Sujet
- Rosopatamab (HuJ591) is a humanized anti-PSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 (177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency.
- Numéro CAS
- 2260767-49-3
-
Vous êtes ici:
